27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Downgrades

Analyst downgrades are often a bearish signal for a stock. When an analyst downgrades a stock it means the stock rating is lower than it previously was and the analyst likely does not recommend people buy the stock. Updated 05/14/2024

No data available to display
date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert

Recent Analyst Stock Rating Downgrades News

JMP Securities Downgrades Capital Southwest to Market Perform
JMP Securities analyst Devin Ryan downgrades Capital Southwest (NASDAQ:CSWC) from Market Outperform to Market Perform.
Scotiabank Downgrades Central North Airport Gr to Sector Underperform
Scotiabank analyst Francisco Suarez downgrades Central North Airport Gr (NASDAQ:OMAB) from Sector Perform to Sector Underperform.
Maxim Group Downgrades Cheetah Net Supply Chain to Hold
Maxim Group analyst Tate Sullivan downgrades Cheetah Net Supply Chain (NASDAQ:CTNT) from Buy to Hold.
Maxim Group Downgrades LuxUrban Hotels to Hold
Maxim Group analyst Allen Klee downgrades LuxUrban Hotels (NASDAQ:LUXH) from Buy to Hold.
Leerink Partners Downgrades Bolt Biotherapeutics to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Daina Graybosch downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Outperform to Market Perform and lowers the price target from $3 to $1.
HSBC Downgrades American Intl Gr to Hold, Announces $86 Price Target
HSBC analyst Vikram Gandhi downgrades American Intl Gr (NYSE:AIG) from Buy to Hold and announces $86 price target.
BTIG Downgrades Ginkgo Bioworks Holdings to Sell
BTIG analyst Mark Massaro downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.
JP Morgan Downgrades Rallybio to Neutral
JP Morgan analyst Anupam Rama downgrades Rallybio (NASDAQ:RLYB) from Overweight to Neutral.
JP Morgan Downgrades Altus Power to Neutral
JP Morgan analyst Mark Strouse downgrades Altus Power (NYSE:AMPS) from Overweight to Neutral.
Jones Trading Downgrades Bolt Biotherapeutics to Hold
Jones Trading analyst Soumit Roy downgrades Bolt Biotherapeutics (NASDAQ:BOLT) from Buy to Hold.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free